Canton Strategic Holdings, Inc. CNTN
Biotechnology: Pharmaceutical Preparations · IPO 2022 · data as of November 13, 2026
Canton Strategic Holdings, Inc. (CNTN) is a healthcare company listed in the US with a market value of about $136M.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (4/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -231%.
About Canton Strategic
Canton Strategic is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2022. It was profitable in 0 of the last 6 years in our data. Its share count rose by 106036% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- More cash than debt, or low debt to equity
- Interest covered more than 5 times
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net income | -$36M | -$12M | -$9M | -$8M | -$2M | -$2M |
| Free cash flow | — | — | — | — | -$1M | -$1M |
| EPS (diluted) | $-1.12 | $-9.41 | $-107.02 | $-280.64 | $-5.25 | $-5.70 |
| Net margin | — | — | — | — | — | — |
| ROIC | -4.3% | -751.2% | -81.8% | -86.1% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Canton Strategic pay a dividend?
Not currently.
Is Canton Strategic a good stock to buy?
We do not give buy or sell advice. Canton Strategic scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.